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INTRODUCTION
Urinary tract infections (UTIs) are one of the most 
common community-acquired infections in older 
adults and their prevalence increases with age. As the 
number of elderly people tends to increase, this type 
of infection will increase in the future, making it im-
perative to improve diagnosis and treatment since ag-
ing causes alterations in the mechanisms of defense 
against infections (1,2).
Urinary tract infections are those infections for which 
ever more money is invested for their treatment since 
they are most prevalent in the general population, as 
well as in the geriatric population, and also are the 
most common cause of bacteremia (3). It is worth not-
ing that the overall number of medical visits for UTIs 
is twice higher among women of all ages compared 
with men (4). 
Urinary tract infections are mostly generated by 
gram-negative bacteria and risk factors have been 
described extensively, such as cardiovascular disease 
(CVD), cognitive and/or functional impairment, 
bladder catheters, and previous antimicrobial treat-
ment (5,6). Th e main routes of infection are ascend-
ing, hematogenous and contiguity (7,8).
In women, the urethral pathway accounts for most of 
UTIs, whereas in men these infections are oft en com-
plicated. It is recognized that the pathogenesis of UTIs 
in the elderly is associated with physiological changes 
caused by the aging itself (9,10).
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Comorbidity is the main predisposing factor for bac-
teriuria in the elderly. In this line, the most frequent 
diseases are benign prostatic hypertrophy, cognitive 
impairment, diabetes mellitus, Parkinson’s disease, 
etc. (11,12). In addition, institutionalized elderly per-
sons are more likely to have a catheter and anatomical 
or functional abnormalities of urinary tract. 
As this type of infection is frequent in geriatric pa-
tients, we must suspect it when there is a change in 
the clinical or functional situation of the elderly (acute 
confusional state, dehydration, falls and immobili-
ty); if the patient has a feverish syndrome, suspicion 
must be even higher (13,14). Notwithstanding, com-
mon symptoms of upper (chills, fever, leukocytosis, 
low back pain, etc.) or lower (bladder tenesmus, low 
abdominal pain, urinary incontinence, urinary tract 
dysuria, etc.) UTI have an atypical presentation in the 
elderly (Table 1) (5).
Table 1.
Symptoms related to urinary tract
General symptoms Local symptoms
- Fever
- Functional impairment






- Frequency of urination
- Bladder tenesmus
- Urgency to urination
- Incontinence
- Abdominal pain
Another aspect to be considered in the elderly is the 
increased risk of infection by classically pathogenic 
nosocomial pathogens, probably related to repetitive 
antibiotic treatments (15). Th e objective of this study 
was to describe the situational status of microbial an-
tibiotic resistance in the elderly aft er reduction of the 
age criteria to be treated in a geriatric service.
METHODS
Th is was a retrospective and descriptive study car-
ried out at the Centro Médico ISSEMYM, Metepec, 
State of Mexico, Mexico. A review of clinical records 
of patients hospitalized with UTIs was performed at 
the Geriatric Service from January 2013 to December 
2015. During the last year, the age criterion to be treat-
ed at the geriatric service was reduced from 65 to 60 
years. Demographic characteristics of patients were 
recorded including age, gender, cause of disease, urine 
culture, microbial identifi cation and antibiogram. 
Patients having taken antibiotics before urine testing 
were excluded from the study but the presence of uri-
nary catheter was not an exclusion factor.
All urine samples were inoculated using standard pro-
cedure in culture media using specifi c Chromoagar for 
isolation of bacilli, cocci and yeast. Th ey were incubat-
ed at 37 °C for 24 hours and aft er incubation, bacteria 
and yeasts were confi rmed by Gram staining. Micro-
bial identifi cation was then carried out through Vitek 
2 cards for fermenting and non-fermenting gram-neg-
ative bacilli, cocci and non-gram-positive spore form-
ing bacilli and yeast and levaduriform organisms, incu-
bated in the Vitek 2 XL (BioMérieux, France), through 
which antibiotic susceptibility was also performed by 
means of microdilution broth based cards, including 
the following groups of antibiotics: a) β-lactams (am-
picillin, ampicillin/sulbactam, aztreonam, piperacil-
lin/tazobactam, benzylpenicillin), b) cephalosporins 
(cefazolin, ceft riaxone, cefepime, ceft azidime, cefalo-
tin, cefuroxime), c) carbapenems (ertapenem, imipen-
em, meropenem), d) aminoglycosides (amikacin, gen-
tamicin, tobramycin), e) quinolones (ciprofl oxacin, 
moxifl oxacin, levofl oxacin), f) glycylglycines (tige-
cycline), g) nitrofurantoin, h) sulfas (trimethoprim/
sulfamethoxazole), i) oxazolidinone (linezolid), and 
j) glycopeptide (vancomycin). Resistance or sensitiv-
ity was determined in accordance with the minimum 
inhibitory concentration (MIC). All data were plotted 
and analyzed in an Excel data sheet.
RESULTS
One hundred and eighty-two geriatric patients (74 
males mean age 81.5±13.5 years and 108 females mean 
age 81.5±11.5 years) with positive urine culture for 
one or more microbial identifi cation and antibiograms 
were included in the analysis.
Th e most common isolations were positive for Esch-
erichia coli BLEE, Escherichia coli, Candida albicans, 
Enterococcus faecalis, Pseudomonas aeruginosa, Prote-
us vulgaris and Klebsiella pneumoniae (Fig. 1).
Generally speaking, for E. coli BLEE there are only two 
options with scarce or null resistance, i.e. carbapen-
ems and glycylglycine. Aminoglycosides off er between 
40% and 50% of sensitivity. Paradoxically, when re-
ducing the age of acceptance to the geriatric service, 
nitrofurantoin showed less sensitivity (Fig. 2).
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Fig. 1. Microbiological isolations per study year.
C.A.: Candida albicans, C.F.: Citrobacter freundii complex, C.G.: 
Candida glabrata, C.K.: Candida krusei, C.P.: Candida parapsilopsis, 
C.T.: Candida tropicalis, E.A.: Enterobacter aerogenes, E.C.: Esche-
richia coli, E.C.B.: Escherichia coli BLEE, E.F.: Enterococcus faecalis, 
E.Fa.: Enterococcus faecium, K.O.: Klebsiella oxytoca, K.P.: Klebsiella 
pneumoniae, P.A.: Pseudomonas aeruginosa, P.M.: Proteus mirabilis, 
P.V.: Proteus vulgaris, S.L.: Staphylococcus lentus.
Fig. 2. Antibiotic resistance (A) and sensitivity (B) for E. coli BLEE.
1: β-lactams (ampicillin, ampicillin/sulbactam, aztreonam, pip-
eracillin/tazobactam), 2: cephalosporins (cefazolin, ceft riaxone, 
cefepime), 3: carbapenems (ertapenem, imipenem, meropenem), 
4: aminoglycosides (amikacin, gentamicin, tobramycin), 5: quino-
lones (ciprofl oxacin, moxifl oxacin), 6: glycylglycines (tigecycline), 
7: nitrofurantoin, 8: sulfas (trimethoprim/sulfamethoxazole).
In the case of Escherichia coli (Fig. 3), the best options 
for sensitivity are also carbapenems and glycylglycine, 
with nitrofurantoin as a third alternative. Practically 
all groups of antibiotics showed better response when 
reducing the age to be treated in the geriatric service.
Enterococcus faecalis (Fig. 4) showed 100% sensitivity 
for glycylglycine and nitrofurantoin in this three-year 
survey. Linezolid had 25% resistance in the year 2013 
and then was 100% eff ective. Vancomycin was the 
fourth most eff ective antibiotic.
Fig. 3. Antibiotic resistance (A) and sensitivity (B) for E. coli.
1: β-lactams (ampicillin, ampicillin/sulbactam, aztreonam, pip-
eracillin/tazobactam), 2: cephalosporins (cefazolin, ceft riaxone, 
cefepime), 3: carbapenems (ertapenem, imipenem, meropenem), 
4: aminoglycosides (amikacin, gentamicin, tobramycin), 5: quino-
lones (ciprofl oxacin, moxifl oxacin), 6: glycylglycines (tigecycline), 
7: nitrofurantoin, 8: sulfas (trimethoprim/sulfamethoxazole).
Fig. 4. Antibiotic resistance (A) and sensitivity (B) for 
Enterococcus faecalis
1: β-lactams (ampicillin, ampicillin/sulbactam, benzylpenicillin), 2: 
aminoglycosides (gentamicin), 3: quinolones (ciprofl oxacin, moxi-
fl oxacin, levofl oxacin), 4: glycylglycines (tigecycline), 5: nitrofuran-
toin, 6: oxazolidinone (linezolid), 7: glycopeptide (vancomycin).
When analyzing the Pseudomonas aeruginosa spec-
trum (Fig. 5), unfortunately the information was in-
complete in 2015, as sulfas and glycylglycines were not 
tested for unknown reasons. Th e best option seems to 
be aminoglycosides and probably tigecycline taking 
into account the antibiogram from 2014.
Klebsiella pneumonia (Fig. 6) showed dramatic im-
provement in the antibiogram within the 3-year peri-
od and the elective antibiotic choice should be tigecy-
cline followed by carbapenems and aminoglycosides.
Aft er widening the age range to enter geriatric service 
(in 2015), there was a reduction in the total cases of 
Escherichia coli BLEE and an increase for Escherichia 
coli. Candida albicans showed no signifi cant chang-
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es. For the less common microorganisms, there was 
an increase that almost doubled the casuistry of the 
previous year (2014) for Citrobacter freundii complex 
and Proteus mirabilis, while a reduction was verifi ed 
for Pseudomonas aeruginosa. Th e rest of the isolated 
agents kept the same percentages.
Fig. 5. Antibiotic resistance (A) and sensitivity (B) for Pseu-
domonas aeruginosa
1: β-lactams (ampicillin, ampicillin/sulbactam, aztreonam, pip-
eracillin/tazobactam), 2: cephalosporins (cefazolin, ceft riaxone, 
cefepime, ceft azidime, cefotaxime), 3: carbapenems (ertapenem, 
imipenem, meropenem), 4: Aminoglycosides (amikacin, gentami-
cin, tobramycin), 5: quinolones (ciprofl oxacin, moxifl oxacin, levo-
fl oxacin), 6: glycylglycines (tigecycline), 7: nitrofurantoin, 8: sulfas 
(trimethoprim/sulfamethoxazole).
Fig. 6. Antibiotic resistance (A) and sensitivity (B) for Klebsi-
ella pneumoniae
1: β-lactams (ampicillin, ampicillin/sulbactam, aztreonam, pip-
eracillin/tazobactam), 2: cephalosporins (cefazolin, ceft riaxone, 
cefepime, ceft azidime, cefalotin, cefuroxime), 3: carbapenems (er-
tapenem, imipenem, meropenem), 4: Aminoglycosides (amikacin, 
gentamicin, tobramycin), 5: quinolones (ciprofl oxacin, moxifl oxa-
cin, levofl oxacin), 6: glycylglycines (tigecycline), 7: nitrofurantoin, 
8: sulfas (trimethoprim/sulfamethoxazole).
DISCUSSION
Th e bacteriological diff erences of UTIs in the elder-
ly are essentially based on the general characteristics 
of the patient, with diff erences attributed to gender 
or place of living (16,17). In a previous study in Latin 
America, Leoni et al. published the isolation and resis-
tance rate for: a) Escherichia coli (67.7% of isolations): 
ampicillin/sulbactam (52.7%), ciprofl oxacin (51.9%), 
trimethoprim/sulfamethoxazole (45.7%), cefotaxime 
(12.9%) and amikacin (3.9%), b) Klebsiella pneumo-
niae (11.97% of isolations): ciprofl oxacin (60.8%), 
trimethoprim/sulfamethoxazole (50%), cefotaxime 
(47.8%) and amikacin (4.7%) and c) Enterococcus spp. 
(9.89% of isolations): ampicillin (0%), vancomycin 
(0%). Th ey also isolated Candida spp. (3.66%), Proteus 
mirabilis (2.6%), Staphylococcus aureus (2.6%), Entero-
bacter cloacae (1.56%) and Pseudomonas aeruginosa 
(1.56%). Th ere was no imipenem resistance among 
gram-negative organisms. Th e isolations were mostly 
monomicrobial and in female gender (18). 
Th e goal of treating UTIs can also be disappearance of 
urinary symptoms but not necessarily general symp-
toms before sterilization of urine. Th is last point can 
only be accepted for patients who have a permanent 
urinary catheter, and in this case, the accuracy of cath-
eter-associated UTIs is a preeminent action before de-
ciding on initiating any antibiotic (19).
As demonstrated worldwide (20,21), a growing in-
crease of resistance against E. coli BLEE has been 
found for β-lactams, cephalosporins of diff erent gen-
erations, quinolones and sulfas, demonstrating that it 
is becoming a public health problem. Th e results of 
this study showed that E. coli BLEE was responsible 
for approximately 40% of UTIs in the geriatric popula-
tion, followed by E. coli. A 100% sensitivity was report-
ed for the cases of E. coli BLEE to carbapenemes and 
glycylcyclines, whereas the sensitivity to third-gener-
ation cephalosporins was reported to be close to 79% 
in 2015. Meanwhile, for E. coli, a 100% sensitivity was 
reported for aminoglycosides and carbapenemes, and 
third-generation cephalosporins were used, yielding 
results close to 93% sensitivity, however, with the use 
of drugs belonging to the group of quinolones, sulfas, 
beta-lactams and penicillins having remained below 
50% during the three years of the present study.
Urinary tract infections by Candida albicans are fre-
quent, reaching the third place in the elderly. Candida 
albicans was present in some cases of our study. In this 
respect, several studies have reported on the ascending 
trend of this infection (22,23). Although the use of fl u-
conazole is still eff ective, its indication can be delayed 
when the treatment is focused only against bacteria. 
When resistance is corroborated, the next options in-
cluding voriconazole, fl ucytosine, or amphotericin B 
are expensive for most patients. 
Enterococcus faecalis is one of the bacteria that pre-
dominates in UTIs, especially in cases of elderly pa-
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tients (24). However, in our study, resistance to several 
types of antibiotics was observed, such as aminoglyco-
sides and quinolones, but showed good sensitivity to 
nitrofurantoin (with the exception of the year 2014), 
as well as to oxazolidinones (linezolid) and glycopep-
tides (vancomycin), thus being good treatment op-
tions against this kind of infection.
In contrast to the literature, in our study, isolated cas-
es of Enterococcus fecalis and Klebsiella pneumoniae 
with 6% each, and Pseudomonas with 3% were low in 
frequency and the rest of UTIs corresponded to even 
more extraordinary cases of other agents.
In our patients, Proteus mirabilis was reported only in 
2015, showing high sensitivity to the institutional anti-
biotics. On the other hand, Pseudomonas aeruginosa is 
not a pathogen associated with UTIs frequently. How-
ever, it causes great mortality in hospitalized patients 
because it produces bacteremia and its association 
with age is fatal (25). Timely diagnosis should be made 
to enable prompt treatment, as shown in Figure 5; this 
bacterium is very resistant to nitrofurantoin and sul-
fas (100%) and is generally resistant to multiple drugs, 
however, it is sensitive to aminoglycosides according 
to our study, so that amikacin, gentamicin or tobramy-
cin may be given as treatment. 
In general, aft er widening the age range to be treated 
in geriatric service, there was an important change in 
the percentages of total cases only for E. coli BLEE and 
E. coli. In the former case, it was accompanied by clear 
reduction in the resistance against quinolones and sul-
fas. For the latter species, the resistance reduction was 
observed for all the tested antibiotics with the excep-
tion of sulfas.
It is clear from this and other studies that treatment of 
any type of symptomatic UTI in the geriatric patient 
should be initiated as soon as possible. Th e choice of 
antimicrobials does not change signifi cantly in rela-
tion to young patients, but variability in the etiology, 
side eff ects, need for dose adjustment and the exis-
tence of comorbidities must be taken into account. 
Some authors indicate that the goal of treatment in the 
elderly patient is the disappearance of symptoms rath-
er than sterilization of the urine. Unfortunately, high 
resistance rates have been observed for all antimicro-
bials among patients aged ≥65 (20). For example, Zec 
et al. did not identify a single antibiotic with either low 
or moderate resistance rates; in fact, all antimicrobi-
al agents showed resistance rates of more than 20% 
(ranging from 26.1% for piperacillin-tazobactam to 
73.7% for ampicillin) (26). Th ese fi ndings are in accor-
dance with numerous studies that also encountered 
high resistance rates among older age groups.
Clinicians should individualize the treatment and 
estimate the probabilities of resistance of a particu-
lar patient, as the fi rst-instance treatment is a quino-
lone formula, but the bacteria are usually resistant, as 
shown in Figure 7; therefore, this treatment should 
be reconsidered. Nitrofurantoin can be administered 
as it has more than 50% eff ectiveness. However, one 
should take into account the type of microorganism. 
Ideally, sensitivity and resistance tests should be per-
formed before implementing the treatment. Th erefore, 
previous history of consumption of some antibiotics is 
fundamental to choosing empiric antibiotic treatment. 
In elderly patients, especially those with a serious clin-
ical situation, previously treated with antimicrobials 
(particularly advanced spectrum cephalosporins), 
or in cases in which the acquisition is related to the 
sanitary environment and those with recurrent UTIs, 
it is advisable to cover against enterococcus until the 
results of the cultures are available. In this sense, ampi-
cillin may be added to the treatment or can be covered 
with piperacillin-tazobactam and an aminoglycoside 
(the latter always in a single daily dose). Regarding 
the duration of treatment, there are no specifi c recom-
mendations for the elderly. In general, long regimens 
of 7 days should be used.
Finally, it is important to mention that antibiotic 
therapy should not be used routinely in people with 
asymptomatic bacteriuria and, where antibiotics are 
required, healthcare professionals should follow local 
prescribing guidelines (6). Developing countries with 
inequities in their national income distribution face 
limited resources for health care (27).
A limitation of this study was that analysis of all groups 
of antibiotics that might be recommended was not al-
ways available, along with the lack of implementation 
of confi rmatory molecular tests. Notwithstanding, 
the microbiological profi le is helpful to characterize 
a population with low/absent carbapenem resistance. 
In general, by reducing the age criterion to be hospi-
talized in a geriatric service, it is expected to get, as a 
collateral benefi t, a decrement in antibiotic resistance 
with unknown time to keep this behavior. 
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Uvod: Infekcije mokraćnog sustava (IMS) su jedna od najčešćih infekcija stečenih u zajednici kod starijih odraslih osoba. 
Metodologija: Ovo je retrospektivna i opisna studija provedena u meksičkoj gerijatrijskoj službi od siječnja 2013. do prosin-
ca 2015. godine. Zabilježene su demografske karakteristike pacijenata, uključujući dob, spol, uzrok bolesti, kulturu urina, 
identifi kaciju mikroorganizama i antibiogram. Cilj ove studije bio je opisati situacijski status mikrobiološke rezistencije 
antibiotika kod starijih osoba nakon smanjenja dobnih kriterija za liječenje u gerijatrijskoj službi. Rezultati: U analizu su bila 
uključena 182 gerijatrijska pacijenta (74 muškarca prosječne dobi 81,5±13,5 godina i 108 žena prosječne dobi 81,5±11,5 
godina) s pozitivnom kulturom urina za jednu ili više bakterijskih identifi kacija i antibiogramima. Najzastupljenije izolacije 
bile su pozitivne za Escherichia coli BLEE, Escherichia coli, Candida albicans, Enterococcus faecalis, Pseudomonas ae-
ruginosa, Proteus vulgaris i Klebsiella pneumoniae. Nakon širenja dobnog raspona za ulazak u gerijatrijsku službu (2015. 
godine) došlo je do smanjenja ukupnih slučajeva Escherichia coli BLEE i povećanja za Escherichia coli. Zaključak: U našem 
je istraživanju pronađeno sve veće povećanje E. coli BLEE. Istodobno je bilo moguće potvrditi da je u većini slučajeva ova 
bakterija pokazala otpornost na b-laktame, cefalosporine različitih generacija, kinolonske antibiotike i sulfa lijekove poka-
zujući da postaje problem javnog zdravstva.
Ključne riječi: amikacin, karbapenemi, starije osobe, rezistencija, osjetljivost, infekcije mokraćnog trakta
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